K

Karolinska Development AB
STO:KDEV

Watchlist Manager
Karolinska Development AB
STO:KDEV
Watchlist
Price: 1.21 SEK 0.17% Market Closed
Market Cap: 323.4m SEK
Have any thoughts about
Karolinska Development AB?
Write Note

Karolinska Development AB
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Karolinska Development AB
Cash & Cash Equivalents Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
K
Karolinska Development AB
STO:KDEV
Cash & Cash Equivalents
kr49.7m
CAGR 3-Years
34%
CAGR 5-Years
35%
CAGR 10-Years
5%
Calliditas Therapeutics AB
STO:CALTX
Cash & Cash Equivalents
kr797.3m
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Cash & Cash Equivalents
kr2.6B
CAGR 3-Years
83%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Cash & Cash Equivalents
kr170m
CAGR 3-Years
-49%
CAGR 5-Years
34%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Cash & Cash Equivalents
kr111.3m
CAGR 3-Years
-26%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Cash & Cash Equivalents
kr882.2m
CAGR 3-Years
23%
CAGR 5-Years
77%
CAGR 10-Years
N/A

See Also

What is Karolinska Development AB's Cash & Cash Equivalents?
Cash & Cash Equivalents
49.7m SEK

Based on the financial report for Jun 30, 2024, Karolinska Development AB's Cash & Cash Equivalents amounts to 49.7m SEK.

What is Karolinska Development AB's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
5%

Over the last year, the Cash & Cash Equivalents growth was -58%. The average annual Cash & Cash Equivalents growth rates for Karolinska Development AB have been 34% over the past three years , 35% over the past five years , and 5% over the past ten years .

Back to Top